In Vivo CAR-T for Multiple Myeloma: Could It Improve Access and Skip Chemotherapy? | IMS 2026

In Vivo CAR-T for Multiple Myeloma: Could It Improve Access and Skip Chemotherapy? | IMS 2026
Etentamig for Relapsed Multiple Myeloma: New Bispecific Shows Strong Results, Low CRS | IMS 2026
Multiple Myeloma Treatment for Older Adults: Who Should Get Quadruplet Therapy? | IMS 2026
What is Ecotherapy? How Nature Therapy Can Help People With Cancer

Should Everyone Get CAR-T at First Relapse in Multiple Myeloma? EMPOWER Consortium Data | IMS 2026
Axi-Cel (Yescarta)-A CD19 Directed CAR-T Cell Product for Lymphoma
Multiple Myeloma Cure: Who Could Be Cured and What Does Cure Mean? | IMS 2026